Your browser doesn't support javascript.
loading
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis.
Rattka, Manuel; Dreyhaupt, Jens; Winsauer, Claudia; Stuhler, Lina; Baumhardt, Michael; Thiessen, Kevin; Rottbauer, Wolfgang; Imhof, Armin.
Afiliación
  • Rattka M; Department of Cardiology, Ulm University Medical Center, Ulm, Germany.
  • Dreyhaupt J; Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
  • Winsauer C; Department of Cardiology, Ulm University Medical Center, Ulm, Germany.
  • Stuhler L; Department of Cardiology, Ulm University Medical Center, Ulm, Germany.
  • Baumhardt M; Department of Cardiology, Ulm University Medical Center, Ulm, Germany.
  • Thiessen K; Department of Cardiology, Ulm University Medical Center, Ulm, Germany.
  • Rottbauer W; Department of Cardiology, Ulm University Medical Center, Ulm, Germany.
  • Imhof A; Department of Cardiology, Ulm University Medical Center, Ulm, Germany armin.imhof@uniklinik-ulm.de.
Heart ; 2020 Dec 17.
Article en En | MEDLINE | ID: mdl-33334863
AIMS: Since the beginning of the SARS-CoV-2 outbreak, hospitals reported declining numbers of patients admitted with ST-segment elevation myocardial infarction (STEMI), indicating that the pandemic might keep patients from seeking urgent medical treatment. However, data on outcomes and mortality rates are inconsistent between studies. METHODS: A literature search and meta-analysis were performed on studies reporting the mortality of patients with STEMI admitted before and during the COVID-19 pandemic using PubMed, Embase and Web of Science. Additionally, prehospital and intrahospital delay times were evaluated. RESULTS: Outcomes of a total of 50 123 patients from 10 studies were assessed. Our study revealed that, despite a significant reduction in overall admission rates of patients with STEMI during the COVID-19 pandemic (incidence rate ratio=0.789, 95% CI 0.730 to 0.852, I2=77%, p<0.01), there was no significant difference in hospital mortality (OR=1.178, 95% CI 0.926 to 1.498, I2=57%, p=0.01) compared with patients with STEMI admitted before the outbreak. Time from the onset of symptoms to first medical contact was similar (mean difference (MD)=33.4 min, 95% CI -10.2 to 77.1, I2=88%, p<0.01) while door-to-balloon time was significantly prolonged in those presenting during the pandemic (MD=7.3 min, 95% CI 3.0 to 11.7, I2=95%, p<0.01). CONCLUSION: The significant reduction in admission of patients with STEMI was not associated with a significant increase of hospital mortality rates. The causes for reduced incidence rates remain speculative. However, the analysed data indicate that acute and timely medical care of these patients has been maintained during the pandemic in most countries. Long-term data on mortality have yet to be determined.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Heart Asunto de la revista: CARDIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Heart Asunto de la revista: CARDIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido